References
- International Association for the Study of Pain (IASP). 2011. www.iasp-pain.org/resources/painDefinition. Accessed August 30, 2012
- Baron R, Toelle T, Gockel U, et al. A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: differences in demographic data and sensory symptoms. Pain 2009;146:34-40
- Hans G, Masquelier E, de Cock P. The diagnosis and management of neuropathic pain in daily practice in Belgium: an observational study. BMC Public Health 2007;7:170
- Bouhassira D, Lant-Minet M, Attal N, et al. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 2008;136:380-7.
- Dieleman J, Kerklaan J, Huygen F, et al. Incidence rates and treatment in neuropathic pain conditions. Pain 2008;137:681-88
- Freynhagen R, Baron R. The evaluation of neuropathic components in low back pain. Curr Pain Headache Rep 2009;13:185-90
- Bekkering G, Bala M, Reid K, et al. Epidemiology of chronic pain and its treatment in the Netherlands. J Med 2011;69:141-52
- Berger A, Dukes EM, Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain 2004;5:143-9
- Oster G, Harding G, Dukes E, et al. Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey. J Pain 2005;6:356-63
- Smith B, Torrance N, Bennett M, et al. Health and quality of life associated with chronic pain of predominantly neuropathic origin in the community. Clin J Pain 2007;23:143-9
- Jensen MP, Chodroff MJ, Dworkin RH. The impact of neuropathic pain on quality of life: review and implications. Neurology 2007;68:1178-82
- O’Connor AB. Neuropathic pain. Pharmacoeconomics 2009;27:95-112
- Doth AH, Hansson PT, Jensen MP, et al. The burden of neuropathic pain: a systematic review and meta-analysis of health utilities. Pain 2010;149:338-44
- Berger A, Sandosky A, Dukes E, et al. Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders: a retrospective cohort study. BMC Neurol 2012;12:8
- Gustavsson A, Bjorkman J, Ljingcrantz C, et al. Socio-economic burden of patients with a diagnosis related to chronic pain – register data of 840,000 Swedish patients. Eur J Pain 2012;16:289-99
- Berger A, Toelle T, Sadosky A, et al. Clinical and economic characteristics of patients with painful neuropathic disorders in Germany. Pain Prac 2009;9:8-17
- Attal N, Lanteri-Minet M, Laurent B, et al. The specific disease burden of neuropathic pain: results of a French nationwide survey. Pain 2011;152:2836-43
- National Health and Wellness Survey (NHWS). 2010; http://www.chsinternational.com/about.html. Accessed August 30, 2012
- Langley PC, Muller-Schwefe G, Nicolaou A, et al. The impact of pain on labour force participation, absenteeism and presenteeism in the European Union. J Med Econ 2010;13:662-72
- Langley PC. The prevalence, correlates and treatment of pain in the European Union. Curr Med Res Opin 2011;27:463-80
- Langley PC, Perez Hernandez C, Margarit Ferri C, et al. Pain, health related quality of life and healthcare resource utilization in Spain. J Med Econ 2011;14:628-38
- Langley PC, Molina JS, Ferri CS, et al. The association of pain with labor force participation, absenteeism, and presenteeism in Spain. J Med Econ 2011;14:835-45
- Langley PC. The societal burden of pain in Germany: health-related quality of life, health status and direct medical costs. J Med Econ 2012; August epub
- Ware JE, Kosinski M, Turner-Bowker DM et al. How to Score Version 2 of the SF-12® Health Survey (With a Supplement Documenting Version 1). Lincoln, RI: QualityMetric Inc, 2002
- Brazier JE, Roberts JR. The estimation of a preference-based index from the SF-12. Med Care 2004;42:851-9.
- Kharroubi S, Brazier JE, Roberts JR, et al. Modelling SF-6D health state preference data using a nonparametric Bayesian method. J Health Econ 2007;26:597-612
- Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993;4:353-65
- Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83
- Winship C, Radbill L. Sampling weights and regression analysis. Soc Methods Res 1994;23:23-57
- Williams AE, Lloyd AC, Watson L, et al. Costs of scheduled and unscheduled asthma management in seven European countries. Eur Resp Rev 2006;15:4-9
- MacDermott A, Toelle T, Rowbotham D, et al. The burden of neuropathic pain: results from a cross sectional survey. Eur J Pain 2006;10:127-35
- Toelle T, Xu X, Sadosky A. Painful diabetic neuropathy: a cross-sectional survey of health state impairment and treatment patterns. J Diab Complications 2006;20:26-33
- DiBonaventura M, Cappelleri JC, Joshi AV. A longitudinal assessment of painful diabetic peripheral neuropathy on health status, productivity, and health care utilization and cost. Pain Medicine 2011;112:118-26
- Poliakov I, Toth C. The impact of pain in patients with polyneuropathy. Eur J Pain 2011;15:1015-22
- Jeffrey M, Butler M, Stark A, et al. Multidisciplinary Pain Programs for Chronic Pain. Technical Brief No 8. Minnesota Evidence-based Practice Center, 2011. AHRQ Publication No. 11-EHC064-EF